Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verrica Pharmaceuticals (VRCA) Shares Issued (2021 - 2025)

Verrica Pharmaceuticals has reported Shares Issued over the past 5 years, most recently at $50.1 million for Q4 2025.

  • Quarterly results put Shares Issued at $50.1 million for Q4 2025, up 5006600.0% from a year ago — trailing twelve months through Dec 2025 was $50.1 million (up 32201.29% YoY), and the annual figure for FY2025 was $50.1 million, up 32201.29%.
  • Shares Issued for Q4 2025 was $50.1 million at Verrica Pharmaceuticals, up from $1000.0 in the prior quarter.
  • Over the last five years, Shares Issued for VRCA hit a ceiling of $50.1 million in Q4 2025 and a floor of -$27.6 million in Q2 2021.
  • Median Shares Issued over the past 5 years was $45000.0 (2021), compared with a mean of $7.1 million.
  • Biggest five-year swings in Shares Issued: crashed 197.61% in 2022 and later soared 5006600.0% in 2025.
  • Verrica Pharmaceuticals' Shares Issued stood at $27.6 million in 2021, then tumbled by 197.61% to -$26.9 million in 2022, then surged by 100.03% to $7000.0 in 2023, then crashed by 85.71% to $1000.0 in 2024, then soared by 5006600.0% to $50.1 million in 2025.
  • The last three reported values for Shares Issued were $50.1 million (Q4 2025), $1000.0 (Q4 2024), and $150000.0 (Q2 2024) per Business Quant data.